Navigation Links
CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease

Paris, France, Friday 13 June 2008: Rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients should undergo compulsory cardiovascular (CV) risk management and existing CV risk calculators should be adapted to the increased CV risk in inflammatory rheumatic disease patients, the EULAR Task Force on 'Cardiovascular Risk Management in RA' recommended today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

RA, AS and PsA are associated with an increased CV risk and, in RA, this risk is at least double the norm and potentially similar to that of type 2 diabetes, a clinically-established cardiovascular risk factor. The EULAR Task Force set out to review existing evidence and expert opinion-based recommendations on CV management in inflammatory rheumatic disease, in order to devise specific EULAR recommendations for future clinical practice.

The EULAR Task Force's multidisciplinary steering committee comprised 21 members, including rheumatologists, cardiologists, internists and epidemiologists, from across nine European countries (France, Germany, Greece, Hungary, Norway, Portugal, Spain, The Netherlands, United Kingdom). Their recommendations were as follows:

  1. RA, AS and PsA should become clinically accepted as new CV risk factors.

  2. Existing CV-risk calculators, such as the Framingham and Systematic Coronary Risk Evaluation (SCORE), should be adapted, by a multiplier, to reflect the increased CV risk in inflammatory rheumatic disease patients.

  3. Annual cardiovascular risk screening is recommended for all RA patients and should be considered for AS and PsA patients.

  4. Lifestyle recommendations (on areas including diet, exercise, smoking cessation and stress management) should be given to all inflammatory rheumatic disease patients.

  5. Treatment with statins and/or antihypertensives should be considered, and the CV management targets should be set according to local guidelines. If there are no local guidelines, treatment should be considered when the 10 year CV mortality risk with the (newly adapted) Framingham/SCORE function is above a certain value.

  6. Aggressive inflammation suppression is recommended to further lower the CV risk in patients with inflammatory rheumatic disease.

Dr Michael Nurmohamed, lead investigator and convenor of this EULAR Task Force said, "Although traditional cardiovascular risk factors occur more frequently in patients with inflammatory rheumatic disease than in the general population, they only partially explain these patients' increased cardiovascular risk. There is mounting evidence that inflammation may be the missing link. Therefore, disease modifying antirheumatic drugs (DMARD) and biologics may lower the cardiovascular risk in inflammatory rheumatic disease patients, whilst statins and hypertensives, such as ACE inhibitors and angiotensin blockers, may even yield greater benefits than in the general population due to their anti-inflammatory properties."

Professor Ferdinand Breedveld, President of EULAR said, "These recommendations have been developed in accordance with the EULAR Standardised Operating Procedures and in line with the EULAR objectives to improve the understanding of musculoskeletal disorders and contribute to the improvement of outcome of patients with rheumatic disorders. The Task Force is to be commended on its excellent recommendations which will directly contribute to improved clinical practice and better understanding of the management of CV factors in rheumatology."

CV risk factor stratification and management is currently conducted on the basis of 10 years absolute risk for a (fatal) CV-event, as derived from a risk formula based on a number of CV-risk factors. The two major standard CV risk calculators are Framingham, a tool based on US population statistics and SCORE, tailored to European populations.


Contact: Rory Berrie / Camilla Dormer
European League Against Rheumatism

Related medicine news :

1. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
2. Rising Medical Solutions Chooses Bank of America to Bring Enhanced Cash Management and Provider Payment Solutions to the Marketplace
3. Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting
4. Benchmarking Study Report on Sales Performance Management
5. New self-management program offers significant benefits for arthritis patients with chronic pain
6. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
7. Medical Mutual of Ohio Receives URAC Utilization Management Accreditation
8. Rush-Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution
9. Weight Management Solution Helps You Lose or Gain as Much Weight as You Choose
10. Aribex(R) Continues Growth With New Management, Organization
11. ECRI Institutes Alert and Recall Management System Expands Effectiveness with New Content and Filters
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... Davie, Florida (PRWEB) , ... November 25, 2015 ... ... PharmaTech LLC has announced that it has undertaken significant expansion of its current ... Florida. The investment is part of PharmaTech’s strategy to increase its manufacturing capacity ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: